<– Back to Publication overview
| Title | Published date | Author | Impact Factor | Journal |
|---|---|---|---|---|
| Medical students as junior adverse drug event managers facilitating reporting of ADRs | 01 December 2021 | Reumerman MO, Tichelaar J, Richir MC, van Agtmael MA | 3.7 | Br J Clin Pharmacol |
| An Interprofessional Student-Run Medication Review Program: The Clinical STOPP/START-Based Outcomes of a Controlled Clinical Trial in a Geriatric Outpatient Clinic | 02 November 2021 | Sultan R, van den Beukel TO, Reumerman MO, Daelmans HEM, Springer H, Grijmans E, Muller M, Richir MC, van Agtmael MA, Tichelaar J | 7.1 | Clin Pharmacol Ther |
| Can Students Create Their Own Educational Escape Room? Lessons Learned from the Opioid Crisis Escape Room | 15 October 2021 | Bakkum MJ, Richir MC, Sultan R, de la Court JR, Lambooij AC, van Agtmael MA, Tichelaar J | 0.5 | Med Sci Educ |
| [The use of analgesics in Dutch oral care from 2016 through 2020] | 14 September 2021 | Brinkman DJ, Brand HS, Rademacher WHM, Bots CP, Rozema FR | 0.1 | Ned Tijdschr Tandheelkd |
| [Use of analgesics in oral care] | 14 September 2021 | Brinkman DJ, Brand HS, Rademacher WHM, Bots CP, Rozema FR | 0.1 | Ned Tijdschr Tandheelkd |
| [Can furosemide mask the use of performance-enhancing drugs?] | 24 May 2021 | Brinkman DJ, Tichelaar J, van Agtmael MA | 0.2 | Ned Tijdschr Geneesk |
| The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions | 12 May 2021 | Reumerman M, Tichelaar J, van Eekeren R, van Puijenbroek EP, Richir MC, van Agtmael MA | 3.1 | Eur J Clin Pharmacol |
| [Making a distinction based on skin colour] | 21 April 2021 | Bakkum M, Muntinga ME, Verdonk P, Tichelaar J | 0.2 | Ned Tijdschr Geneesk |
| The European list of Essential Medicines for Medical Education, A protocol for a modified delphi study | 15 April 2021 | Donker E, Brinkman D, Richir M, Papaioannidou P, Likic R, Sanz EJ, Christiaens T, Costa J, De Ponti F, Gatti M, Böttiger Y, Kramers C, Garner S, Pandit R, van Agtmael MA, Tichelaar J | 3.0 | BMJ Open |
| Medical students as adverse drug event managers, learning about side effects while improving their reporting in clinical practice | 05 March 2021 | Reumerman M, Tichelaar J, Richir MC, van Agtmael MA | 3.2 | Naunyn Schmiedebergs Arch Pharmacol |
| EurOP2E - the European Open Platform for Prescribing Education, a consensus study among clinical pharmacology and therapeutics teachers | 23 February 2021 | Bakkum MJ, Richir MC, Papaioannidou P, Likic R, Sanz EJ, Christiaens T, Costa JN, Mačiulaitis R, Dima L, Coleman J, Tichelaar J, van Agtmael MA | 3.1 | Eur J Clin Pharmacol |
| Harmonizing and improving European education in prescribing: An overview of digital educational resources used in clinical pharmacology and therapeutics | 01 February 2021 | Bakkum MJ, Tichelaar J, Papaioannidou P, Likic R, Sanz EJ, Christiaens T, Costa JN, Mačiulaitis R, Dima L, Coleman J, Richir MC, van Agtmael MA | 3.7 | Br J Clin Pharmacol |
| Switching from a traditional undergraduate programme in (clinical) pharmacology and therapeutics to a problem-based learning programme | 01 February 2021 | Brinkman DJ, Monteiro T, Monteiro EC, Richir MC, van Agtmael MA, Tichelaar J | 3.1 | Eur J Clin Pharmacol |
| The Pharmacotherapy team: a novel strategy to improve appropriate in-hospital prescribing using a participatory intervention action method | 01 February 2021 | Mahomedradja RF, Sigaloff KCE, Bekema JK, Brinkman DJ, Kuijvenhoven MA, van Beneden M, Dekker MJHJ, Lissenberg-Witte BI, Tichelaar J, van Agtmael MA | 3.7 | Br J Clin Pharmacol |
| [Recognize and report your side effect] | 24 January 2021 | Reumerman MO, Richir MC, van Ekeren R, van Agtmael MA, Tichelaar J | 4.3 | Oncologica |
| The clinical and educational outcomes of an inter-professional student-led medication review team, a pilot study | 11 January 2021 | Reumerman MO, Richir MC, Nieuwenhuis PM, Sultan R, Daelmans HE, Springer H, Muller M, van Agtmael MA, Tichelaar J | 3.1 | Eur J Clin Pharmacol |